Abstract
Background
obesity and its associated type II diabetes mellitus (Type II DM) are an ongoing health-care problem worldwide. Both diseases are closely related and difficult to control by current medical treatment, including diet, drug therapy and behavioral modification. There is strong evidence that bariatric surgery can cure type II diabetes mellitus in patients with obesity.
Aim of the Work
to determine different predictive factors affecting the outcome of type II diabetes mellitus after laparoscopic sleeve gastrectomy.
Patients and Methods
this prospective study included 40 obese diabetic patients with type II DM who underwent laparoscopic sleeve gastrectomy. DM type II was diagnosed according to ADA criteria: FPG > 126 mg/dl, HbA1c ≥ 6.5%, random blood glucose ≥200 mg/dl, or use of insulin or oral diabetes medication. Glycemic marker in the form of HbA1c and fasting blood sugar were measured just prior to surgery and at 3 months and 6 months postoperatively.
Results
a total of 40 patients (70% women) with T2DM were included in the study. Mean age at the time of surgery was 42.48 ± 10.95 years. Median Inter Quartile Ratio (IQR) of diabetes age (diabetes age was calculated from the diagnose date to the operation date) was 4 years (from 3 years to 6 years) with range of 1-20 years. Remission of T2DM was achieved in 42.5% of patients underwent SG.
Conclusion
This study showed that younger patients, with shorter diabetic age, not using insulin and optimum pre-operative glycemic control(normal fasting blood sugar and HbA1c) were the best candidates to achieve remission (HbA1c <6.5% and no need for antidiabetics) after SG.
Wight Loss And Type II Diabetes Mellitus Control After Laparoscopic Sleeve Gastrectomy In An Early Post-Operative Period- A Prospective Cohort Study